Medinet Co Ltd
TSE:2370
Intrinsic Value
MEDINET Co., Ltd. engages in cell processing business. [ Read More ]
The intrinsic value of one Medinet Co Ltd stock under the Base Case scenario is 9.9 JPY. Compared to the current market price of 45 JPY, Medinet Co Ltd is Overvalued by 78%.
Valuation Backtest
Medinet Co Ltd
Run backtest to discover the historical profit from buying and selling Medinet Co Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Medinet Co Ltd
Current Assets | 5.4B |
Cash & Short-Term Investments | 5B |
Receivables | 225.2m |
Other Current Assets | 135.2m |
Non-Current Assets | 955.2m |
Long-Term Investments | 296.2m |
PP&E | 483.6m |
Intangibles | 113.4m |
Other Non-Current Assets | 62m |
Current Liabilities | 272.9m |
Accounts Payable | 50.2m |
Accrued Liabilities | 30.7m |
Other Current Liabilities | 192m |
Non-Current Liabilities | 275.7m |
Other Non-Current Liabilities | 275.7m |
Earnings Waterfall
Medinet Co Ltd
Revenue
|
724.6m
JPY
|
Cost of Revenue
|
-596.2m
JPY
|
Gross Profit
|
128.4m
JPY
|
Operating Expenses
|
-1.5B
JPY
|
Operating Income
|
-1.4B
JPY
|
Other Expenses
|
10.4m
JPY
|
Net Income
|
-1.4B
JPY
|
Free Cash Flow Analysis
Medinet Co Ltd
Profitability Score
Profitability Due Diligence
Medinet Co Ltd's profitability score is 19/100. The higher the profitability score, the more profitable the company is.
Score
Medinet Co Ltd's profitability score is 19/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Medinet Co Ltd's solvency score is 69/100. The higher the solvency score, the more solvent the company is.
Score
Medinet Co Ltd's solvency score is 69/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Medinet Co Ltd
Shareholder Return
Price
Medinet Co Ltd
Average Annual Return | 0.68% |
Standard Deviation of Annual Returns | 24.95% |
Max Drawdown | -76% |
Market Capitalization | 11.4B JPY |
Shares Outstanding | 256 489 936 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
MEDINET Co., Ltd. engages in cell processing business. The company is headquartered in Ota-Ku, Tokyo-To and currently employs 83 full-time employees. The company went IPO on 2003-10-08. The company operates through two business segments. The Cell Processing Industry segment mainly engages in comprehensive support services for immune cell therapy, related services including clinical use from companies, universities, research institutes, outsourcing of cell processing for clinical trials and operation of cell culture processing facilities. The Cellular Medical Products segment is mainly engaged in research and development for obtaining approval for manufacture and marketing of cellular medical products. The company also provides comprehensive support services for immune cell therapy.
Contact
IPO
Employees
Officers
The intrinsic value of one Medinet Co Ltd stock under the Base Case scenario is 9.9 JPY.
Compared to the current market price of 45 JPY, Medinet Co Ltd is Overvalued by 78%.